Several new markers have been introduced as alternative means to refine risk estimation beyond LDL-c in the presence of cardiovascular disease, such as non-HDL-c, TC/HDL-c ratio, and the apoB/apoA1 ratio [18, 22]. The gene discussed is APOB; the disease is cardiovascular disorder.